SCHEMBL3676349

SCHEMBL3676349

COc1ccc2c(O)c(CCOCc3ccccc3)c(=O)oc2c1OC1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
HTT P42858 2/20 0.46
POLB P06746 2/20 0.46
GAA P10253 1/20 0.46
PDE4B Q07343 4/20 0.40
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
NQO1 P15559 1/20 0.39
HPGD P15428 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MIF P14174 1/20 0.38
PDE4A P27815 4/20 0.37
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3681794 0.89 ALDH1A1 (0.46) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL3682003 0.82 PDE4B (0.58) PDE4BPDE4APDE4CPDE4D
SCHEMBL8945415 0.69 NQO1 (0.64) ALDH1A1NQO1PDE4DMEN1KMT2A
SCHEMBL3678492 0.69 PDE4B (0.62) ALDH1A1KDM4EPDE4BHPGDPDE4A
SCHEMBL3679926 0.67 PDE4B (0.48) ALDH1A1KDM4EHTTPOLBGAA
SCHEMBL3676851 0.66 PDE4B (0.65) PDE4BPDE4APDE4CPDE4D
SCHEMBL3675552 0.66 PDE4B (0.60) ALDH1A1KDM4EPDE4BHPGDPDE4A
SCHEMBL8945527 0.66 NQO1 (0.61) ALDH1A1NQO1PDE4DMEN1KMT2A
SCHEMBL3676425 0.66 PDE4B (0.70) PDE4BPDE4APDE4CPDE4D
SCHEMBL3675535 0.65 PDE4B (0.68) ALDH1A1KDM4EPDE4BHPGDPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745646-B2 Bicyclic heteroaryl inhibitors of PDE4 KALYPSYS, INC. (US) 2010-06-29 US disclosed
US-20080027112-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 Govek, Steven (US) 2008-01-31 US disclosed
WO-2008006051-A2 BICYCLIC HETEROARYL INHIBITORS OF PDE4 GOVEK STEVEN P (US) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027112-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C ALDH1A1 890/4885KDM4E 1489/4885HTT 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.